A detailed history of Epoch Investment Partners, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 14,131 shares of NVO stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,131
Previous 14,132 0.01%
Holding current value
$1.48 Million
Previous $2.02 Million 16.61%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $119 - $145
-1 Reduced 0.01%
14,131 $1.68 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $75,343 - $90,202
614 Added 4.54%
14,132 $2.02 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $125,799 - $167,453
-1,232 Reduced 8.35%
13,518 $1.74 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $73,822 - $88,683
841 Added 6.05%
14,750 $1.53 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $655,859 - $1.44 Million
7,212 Added 107.69%
13,909 $1.26 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $1.13 Million - $1.25 Million
-7,254 Reduced 52.0%
6,697 $1.08 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $10,719 - $12,890
-81 Reduced 0.58%
13,951 $2.22 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $31,072 - $41,004
303 Added 2.21%
14,032 $1.9 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $21,819 - $26,776
-229 Reduced 1.64%
13,729 $1.37 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $105,098 - $124,002
-1,018 Reduced 6.8%
13,958 $1.56 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $1.39 Million - $1.69 Million
14,976 New
14,976 $1.66 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.